Effect of sialidase fusion protein (DAS 181) on human metapneumovirus infection of Hep-2 cells

Antiviral Chemistry and Chemotherapy

Volumn 24, Issue 5-6, 2015, Pages 161-165

  Thammawat, Sutthiwan ^a,b   Sadlon, Tania A ^a   Adamson, Penelope ^a   Gordon, David L ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b MAHASARAKHAM UNIVERSITY   (Thailand)

Author keywords

attachment; DAS181; Human metapneumovirus; infectivity; sialic acids; sialidase fusion protein

Indexed keywords

ANTIVIRUS AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; MATRIX PROTEIN; SIALIC ACID DERIVATIVE; SIALIDASE FUSION PROTEIN; UNCLASSIFIED DRUG; DAS181; FUSION PROTEIN; GLYCOPROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL LINE; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IN VITRO STUDY; INOCULATION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ATTACHMENT; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; PARAMYXOVIRUS INFECTION; RHESUS MONKEY;

ANIMALS; CELL LINE; GLYCOPROTEINS; HUMANS; MACACA MULATTA; PARAMYXOVIRIDAE INFECTIONS; RECOMBINANT FUSION PROTEINS; VIRUS REPLICATION;

EID: 85007174194     PISSN: None     EISSN: 20402066     Source Type: Journal    
DOI: 10.1177/2040206616665971     Document Type: Article

References (15)

1. van den Hoogen BG, Osterhaus DM, Fouchier RA. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J 2004; 23: S25–S32.
2. Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006; 19: 546–557.
3. Thammawat S, Sadlon TA, Hallsworth PG. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J Virol 2008; 82: 11767–11774.
4. Olofsson S, Bergström T. Glycoconjugate glycans as viral receptors. Ann Med 2005; 37: 154–172.
5. Suzuki Y, Nagao Y, Kato H. The hemagglutinins of the human influenza viruses A and B recognize different receptor microdomains. Biochim Biophys Acta 1987; 903: 417–424.
6. Malakhov MP, Aschenbrenner LM, Smee DF. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother 2006; 50: 1470–1479.
7. Chan RW, Chan MC, Wong AC. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother 2009; 53: 3935–3941.
8. Belser JA, Lu X, Szretter KJ. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007; 196: 1493–1499.
9. Moss RB, Hansen C, Sanders RL. A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J Infect Dis 2012; 206: 1844–1851.
10. Cox RG, Williams JV. Breaking in: human metapneumovirus fusion and entry. Viruses 2013; 5: 192–210.
11. Feldman SA, Hendry RM, Beeler JA. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 1999; 73: 6610–6617.
12. Schowalter RM, Pastrana DV, Buck CB. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog 2011; 7e: 1002161.
13. Neu U, Hengel H, Blaum BS. Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog 2012; 8: e1002738.
14. Martínez I, Melero JA. Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J Gen Virol 2000; 81: 2715–2722.
15. Wen SC, Williams JV. New approaches for immunization and therapy against human metapneumovirus. Clin Vaccine Immunol 2015; 22: 858–866.